About
About Us
Management
Board of Directors
Scientific Advisory Board
Partnership Inquiries
Pipeline
Overview
Annamycin
WP1122
WP1066
WP1220
Disease Areas
Acute Myeloid Leukemia (AML)
Soft Tissue Sarcoma (STS)
Scientific Publications and Presentations
Clinical Studies
MIRACLE: Pivotal, Adaptive Phase 3 Study in AML
MB-107: Phase1B/2 Study in STS Lung Mets
Completed: MB-106 Phase 1B/2 Study in AML
Expanded Access
Investors
Overview
News
Events
Presentations
Analyst Coverage
Company Info
Profile
Management
FAQ
Investor Contacts
Financial Info
Annual Report and Proxy
Stock Data
SEC Filings
Governance
Email Alerts
Contact
Select Page
Sign up for Alerts
